NATALIA LAPTEVA to Central Nervous System Neoplasms
This is a "connection" page, showing publications NATALIA LAPTEVA has written about Central Nervous System Neoplasms.
Connection Strength
0.188
-
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. J Clin Oncol. 2024 Aug 10; 42(23):2769-2779.
Score: 0.188
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.